World Bulletin / News Desk
The Netherlands on Thursday made a formal bid to become the new home of the European Medicines Agency which will likely have to relocate from London after Britain leaves the EU.
"It is my pleasure to inform you of the Netherlands' candidacy to host the European Medicines Agency (EMA) in Amsterdam," Dutch Prime Minister Mark Rutte said in a letter to EU president Donald Tusk.
The agency and its 900 staff of pharmacists, biologists and doctors are tasked with researching and evaluating all new medicines to see if they are ready to be rolled out across the bloc.
Amsterdam has "outstanding international travel connections and excellent working and living conditions," Rutte said, adding it "meets all the requirements of the agency and its staff".
Several European cities are thought to be in the running to provide a new home for the EMA, including reportedly Dublin, Barcelona and Copenhagen.
"The Netherlands will do everything in its power to facilitate a smooth and efficient transition from the UK to our country, in order to ensure full operational continuity both for the agency and the large number of scientific experts involved," Rutte vowed.
He said "uncertainty about the move" was already affecting the agency's work and staff and he urged the European Council to "decide on the EMA’s new location as swiftly as possible".
European Commission spokesman Margaritis Schinas said Wednesday the "real political" negotiations on Brexit will start after Britain's snap June 8 elections.
He told reporters that both the EMA and the European Banking Authority "must be based in the territory of the European Union" once Brexit is complete.
The British government will have "no say" on the issue because it is not part of the Brexit negotiations, but "will have to ease the burden of relocating" staff to EU cities, he added.
Rutte also took to Twitter to press his country's case saying on his official account: "I firmly believe that NL is best equipped to provide all conditions necessary to enable #EMA to perform its work as effectively as possible."
Since its creation in 1995, the agency has approved 1,100 medicines, including 82 last year.
Of those which gained approval in 2016, 17 were for treating cancer, 14 for infections, and nine for heart disease.
Since mid-October, Peshmerga have withdrawn from vast majority of ‘disputed’ parts of Iraq, Kurdish official says
Nearly 63 percent of 2,000 American participants oppose moving US Embassy to Jerusalem, survey indicates
Tensions continue to mount in occupied territories following US recognition of Jerusalem as Israel’s capital
Defeat leaves Republicans with razor thin 51-49 majority in Senate
President Donald Trump has not changed his position on North Korea but does not oppose efforts to initiate talks
'Trump you failed to protect your nation,' Akayed Ullah allegedly wrote on Facebook
Vast areas have been destroyed, hundreds of thousands of people have been evacuated and thousands of firefighters are working around the clock.
Trade dispute ends Boeing’s CAN$19 billion bid to replace aging CF-18s fighters
One third of those detained are minors, Palestinian activists say
ISIL has recently suffered a string of defeats in Iraq and Syria
Turkish deputy premier says some leading Greek Cypriots say they would prefer to 'drink poison' than use Turkish water
'I want to shoot a movie in Jerusalem when it is liberated,' says Nawras Abu Saleh
After meeting in Ottawa with officials from the nation's 10 provinces and three territories, Finance Minister Bill Morneau said he has agreed to give the provinces 75 percent of the monies.
Maduro's ruling socialists triumphed as expected in mayoral polls Sunday, taking 300 of the country's 335 mayorships after a boycott by the main opposition parties.
US president revises space agency’s policy, undoing Obama’s concentration on Mars
US-led global coalition will continue to operate and support local forces in Syria, Pentagon spokesman says